摘要 |
FIELD: medicine.SUBSTANCE: agent contains riboflavin mononucleotide, hydroxypropyl methylcellulose, sodium chloride, tris-(hydroxymethyl)-methylamine, Nipagin, Trilon B in a certain ratio, wt %: 0.24-0.26, 0.4-0.6, 0.8-0.9, 0.08-0.12, 0.0075-0.0125, 0.005-0.01 and purified distilled water up to 100 respectively.EFFECT: using the invention enables increasing the transepithelial penetration of riboflavin ensured by increasing its concentration, and preventing the corneal thinning.1 ex |